SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a)
of the Securities Exchange Act of 1934
Amendment No. ____)
Filed by the Registrant [X]
Filed by a Party other than the Registrant [ ]
Check the appropriate box:
[ ] Preliminary Proxy Statement
[ ] Confidential, for Use of the Commission Only (as permitted by Rule
14a-6(e))
[X] Definitive Proxy Statement
[ ] Definitive Additional Materials
[ ] Soliciting material pursuant to ss. 240.14a-11(c) or ss. 240.14a-12
ORALABS HOLDING CORP.
- --------------------------------------------------------------------------------
(Name of Registrant as Specified in Charter)
- --------------------------------------------------------------------------------
(Name of Person(s) Filing Proxy Statement if Other Than the Registrant)
Payment of Filing Fee (Check the appropriate box):
[X] No fee required
[ ] Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11
1) Title of each class of securities to which transaction applies:
2) Aggregate number of securities to which transaction applies:
3) Per unit price or other underlying value of transaction computed pursuant
to Exchange Act Rule 0- 11 (set forth the amount on which the filing fee is
calculated and state how it was determined):
4) Proposed maximum aggregate value of transaction:
5) Total fee paid:
[ ] Fee paid previously with preliminary materials.
[ ] Check box if any part of the fee is offset as provided by Exchange Act Rule
0-11(a)(2) and identify the filing for which the offsetting fee was paid
previously. Identify the previous filing by registration statement number,
or the Form or Schedule and the date of its filing.
1) Amount previously paid:
2) Form, Schedule or Registration Statement Number:
3) Filing party:
4) Date filed:
<PAGE>
ORALABS HOLDING CORP.
2901 South Tejon Street
Englewood, Colorado 80110
----------------------
NOTICE OF ANNUAL MEETING OF STOCKHOLDERS
----------------------
May 25, 2000
NOTICE IS HEREBY GIVEN that the Annual Meeting of Stockholders of ORALABS
HOLDING CORP. (the "Company") will be held at the Company's offices at 2901
South Tejon Street, Englewood, Colorado 80110, on Thursday, May 25, 2000, at
11:00 a.m., for the following purposes:
1. To elect three Directors;
2. To ratify the selection of Ehrhardt Keefe Steiner & Hottman P.C. as the
Company's independent auditors for the fiscal year ending December 31, 2000; and
3. To transact such other business as may properly come before the meeting
or any adjournment(s) thereof.
The Board of Directors has fixed the close of business on April 3, 2000 as
the record date for determining all stockholders entitled to receive notice of
the Annual Meeting and to vote at such meeting or any adjournment(s) thereof.
The Board of Directors appreciates and welcomes stockholder participation
in the Company's affairs. Whether or not you plan to attend the Annual Meeting,
please vote by completing, signing and dating the enclosed proxy and returning
it promptly to the Company in the enclosed self-addressed, postage-prepaid
envelope. If you attend the meeting, you may revoke your proxy and vote your
shares in person.
By Order of the Board of Directors,
/s/ Allen R. Goldstone
----------------------
Allen R. Goldstone, Secretary
April 24, 2000
<PAGE>
ORALABS HOLDING CORP.
2901 South Tejon Street
Englewood, Colorado 80110
----------------------
PROXY STATEMENT
----------------------
ANNUAL MEETING OF STOCKHOLDERS
May 25, 2000
General Information
This Proxy Statement is furnished to the stockholders of OraLabs Holding
Corp., a Colorado corporation (the "Company"), in connection with the
solicitation of proxies by the Board of Directors of the Company (the "Board of
Directors") for use at the Annual Meeting of Stockholders of the Company to be
held on May 25, 2000, and any adjournment(s) thereof (the "Annual Meeting"). A
copy of the notice of meeting, the Company's Annual Report on Form 10-KSB for
the fiscal year ended December 31, 1999 (which also comprises the Company's
Annual Report) and form of proxy statement are first being sent to stockholders
on or about April 27, 2000.
Only stockholders of record at the close of business on April 3, 2000, the
record date for the Annual Meeting, will be entitled to notice of and to vote at
the Annual Meeting. On the record date, there were issued and outstanding
9,160,755 shares of the Company's Common Stock, par value $.001 per share (the
"Common Stock"). Each share of Common Stock entitles the holder to one vote with
respect to each of the matters to be voted upon at the Annual Meeting. The
Common Stock is the only class of outstanding securities of the Company entitled
to vote at the Annual Meeting.
Presence in person or by proxy of the holders of 4,580,378 shares of Common
Stock will constitute a quorum at the Annual Meeting. Assuming a quorum is
present, the affirmative vote of the holders of at least a majority of votes
present and entitled to be cast at the Annual Meeting is required for (i) the
election of Directors, (ii) the ratification of the selection of Ehrhardt Keefe
Steiner & Hottman P.C. as independent auditors for the current fiscal year, and
(iii) except as otherwise required by Colorado law or the Company's Articles of
Incorporation or Bylaws, any other matters that properly come before the
meeting. If a stockholder, present in person or by proxy, abstains on any
matter, the stockholder's shares will not be voted on such matter. Abstentions
may be specified on all proposals submitted to a stockholder vote other than the
election of directors. Abstentions will be counted as present or represented and
entitled to vote for purposes of determining the existence of a quorum regarding
the proposal on which the abstention is noted, but will not be considered as
votes cast in determining whether a matter has been approved by the
1
<PAGE>
stockholders. A proxy submitted by a stockholder also may indicate that all or a
portion of the shares represented by such proxy are not being voted by such
stockholder with respect to a particular matter. This could occur, for example,
when a broker is not permitted to vote shares held in street name on certain
matters in the absence of instructions from the beneficial owner of the shares.
If a proxy in the accompanying form is properly executed and returned, the
shares represented thereby will be voted as instructed in the proxy. If no
instructions are given, the persons named in the proxy intend to vote in favor
of (i) the nominees for election as Directors as set forth below and (ii) the
ratification of the selection of Ehrhardt Keefe Steiner & Hottman P.C. as
independent auditors for the current fiscal year.
Brokers holding shares in street name, who do not receive instructions, are
entitled to vote on the election of Directors and ratification of the
appointment of the independent auditors, since such matters are considered to be
routine. Since a broker is not required to vote shares held in "street name" in
the absence of instructions from the beneficial stockholder, a stockholder's
failure to instruct his broker may result in the stockholder's shares not being
voted.
Each proxy granted may be revoked by the person granting it at any time (i)
by giving written notice to such effect to the Secretary of the Company, (ii) by
execution and delivery of a proxy bearing a later date, or (iii) by attendance
and voting in person at the Annual Meeting, except as to any matter upon which,
prior to such revocation, a vote shall have been taken pursuant to the authority
conferred by such proxy. The mere presence at the Annual Meeting of a person
appointing a proxy does not revoke the appointment.
ELECTION OF DIRECTORS
Nominees
The Bylaws of the Company provides that the number of Directors of the
Company shall be fixed by resolution of the Board of Directors. Such number
currently has been fixed at four persons, but there is a vacancy so only three
persons currently serve as directors. At the Annual Meeting, three persons will
be elected to the Board of Directors to serve until the next annual meeting and
until their successors have been elected and qualify. The persons named as
proxies in the accompanying proxy intend to vote FOR these nominees of the Board
of Directors or, if any of the nominees should be unable to serve, for such
substitute nominee(s) as the Board of Directors then may propose.
The following table sets forth information about the nominees, each of whom
is currently serving as a Director of the Company:
2
<PAGE>
Year First
Elected to
Board of
Name Age Positions with the Company Directors
---- --- -------------------------- ---------
Gary H. Schlatter(2)..........43 Chairman of the Board, Chief 1997
Executive Officer, Director(1)
Allen R. Goldstone(2).........47 Director(1), Secretary 1997
Michael I. Friess.............50 Director(1) 1997
- ----------
(1) Audit Committee member
(2) See "Certain Relationships and Related Transactions" below.
Mr. Schlatter and Mr. Goldstone were elected to their positions in May 1997
upon consummation of the transaction by which the Company's subsidiary, OraLabs,
Inc., was acquired by SSI Capital Corp. (the Company's predecessor). Mr. Friess
was appointed as a Director on September 8, 1997. All directors serve as such
until their successors are elected and qualified. No family relationship exists
among the Directors or between any of such persons and the Executive Officers of
the Company. Mr. Goldstone resigned from the Board on August 24, 1999, shortly
after the completion of the transaction under which the Company obtained a
minority interest in a company which acquired Pecos Pharmaceuticals (see,
"Certain Relationships and Related Transactions"). Mr. Goldstone was reappointed
to the Board on December 30, 1999.
Gary H. Schlatter is the founder (in 1990) of the Company's subsidiary,
OraLabs, Inc. (which became the name of the subsidiary in 1994), and has served
as the President, Chief Executive Officer, Treasurer and Secretary of the
subsidiary since that time. He also serves in the positions listed in the above
table with respect to the Company. Mr. Schlatter holds his offices (other than
the position of director) pursuant to an employment agreement (see, "Executive
Compensation").
Michael Friess is a self-employed attorney licensed to practice law in the
state of Colorado. He was a partner from January 1983 to December 1993 in the
New York City law firm of Schulte, Roth & Zabel, where his practice emphasized
taxation.
Allen R. Goldstone is the managing member of Creative Business, LLC, a
company which is engaged in business consultation, and he has held that position
since 1998 (and prior thereto he was and still serves as president of Creative
Business Strategies, Inc., another business consulting firm). Mr. Goldstone has
also served as a management consultant since 1988. For calendar year 1997, Mr.
Goldstone was an employee of the Company's subsidiary, in which capacity he was
in charge of investor relations.
3
<PAGE>
Involvement in Certain Legal Proceedings.
As previously report, in December 1999 the Company's president, Gary
Schlatter, was charged with two violations of the United States Code as part of
a Criminal Complaint filed in the United States District Court for the Central
District of California. The charges were dismissed in January 2000. The Company
provided shipping and other ancillary services to Mr. Schlatter's company, Top
Form Brands, Inc., pursuant to a contract between the Company and Top Form
Brands which was effective April 1, 1998 and terminated as of June 30, 1999 (see
"Certain Relationships and Related Transactions" below). The Company was not
named in the Criminal Complaint and no charges were brought against the Company
(see, "Charges Against the Company's President" in the Company's Form 10-KSB for
the fiscal year ended December 31, 1999).
The Board of Directors recommends that stockholders vote FOR the election
of each of the nominees named herein.
Additional information with respect to the Board of Directors.
The Company has a standing Audit Committee. It did not meet in 1999 because
functions of the Audit Committee were performed by the entire Board.
During the fiscal year ended December 31, 1999, the Board of Directors met
four (4) times, and each Director attended all of the meetings. The Board also
took action on several occasions by unanimous consent, without a formal meeting.
Section 16(a) Beneficial Ownership Reporting Compliance.
Based solely upon a review of Forms 3, 4 and 5 filed with the Securities
and Exchange Commission and the Company under the Securities Exchange Act of
1934 (the "Exchange Act") and a review of written representations received by
the Company, no person who at any time during fiscal 1999 was a Director,
Executive Officer or beneficial owner of more than 10% of the outstanding shares
of Common Stock failed to file, on a timely basis, reports required by Section
16(a) of the Exchange Act.
Executive Officers and Significant Employees.
The following table sets forth information about the executive officers and
significant employees of the Company:
Name Age Positions with the Company
---- --- --------------------------
Gary H. Schlatter(1)............43 Chief Executive Officers, President,
Treasurer
Emile (Red) Jordan..............41 Comptroller, Chief Financial
Officer
Christopher Farnworth...........44 Technical Director for OraLabs, Inc.
(subsidiary of Company)
- ------------------
(1) See description of Mr. Schlatter below the table of Nominees to the Board
of Directors, above.
4
<PAGE>
Mr. Jordan has served as the Comptroller of the Company since May 1997. He
has served as Comptroller of the subsidiary, OraLabs, on a full time basis since
April 1, 1994. Mr. Jordan is the Chief Financial Officer of the Company. Mr.
Jordan was elected to his position by the Board of Directors of the Company and
holds his office at the discretion of the Board of Directors or until his
earlier death or resignation.
Although Mr. Farnworth is not an executive officer of the Company or of the
Company's subsidiary, in his capacity as Technical Director of the subsidiary,
he makes a significant contribution to the business of the Company. In such
capacity, Mr. Farnworth is responsible for engineering and maintenance of the
Company's production equipment. He has served in the capacity of Technical
Director of the subsidiary since September 1996, and he began working for
OraLabs in 1992.
CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS
Gary H. Schlatter is the owner of the property leased by OraLabs (the
Company's subsidiary) which serves as the Company's headquarters, manufacturing
facility and one of OraLabs' two warehouse facilities. The lease expires in
September 2000. Mr. Schlatter, through an entity, is also the owner of property
leased by OraLabs which serves as its second warehouse facility. That lease
expires in June 2003. The Company believes that its rental rates are comparable
to that which would be paid to unaffiliated parties, and the Company believes
that if the leases were not to be renewed, alternative space could be obtained
by the Company.
Mr. Schlatter is also the owner of Top Form Brands, Inc., ("Top Form"). In
April 1998, Top Form entered into a Contract for Services with OraLabs, Inc.
under which OraLabs provided warehousing, shipping and accounting services for
products sold on a wholesale basis by Top Form. OraLabs was compensated by
payment of a fixed price per case of product it shipped for Top Form and was
reimbursed for any out-of-pocket costs advanced by it. The disinterested members
of the Board of Directors of the Company determined that the Contract for
Services was fair to OraLabs and that the services to be performed by Mr.
Schlatter on behalf of Top Form were of a limited nature and did not constitute
a violation of his employment relationship with OraLabs. The Contract for
Services terminated as of June 30, 1999. (See, "Involvement in Certain Legal
Proceedings" concerning charges filed and dismissed against Mr. Schlatter
relating to the business activities of Top Form.)
5
<PAGE>
In August 1999, the Company completed a transaction by which the Company
received a minority interest in an entity formed to acquire Pecos
Pharmaceuticals, which is engaged in the sale of nutritional supplements. The
Company agreed that Creative Business, LLC, an entity owned by Allen R.
Goldstone, was entitled to a brokerage fee for its services in presenting the
opportunity of the transaction to the Company and assisting in closing the
transaction on terms favorable to the Company. Under the Agreement, Creative
Business, LLC received a fee of $125,000 as well as a 25% interest in
distributions which the Company may receive as a result of its ownership
interest acquired in the transaction.
SECURITY OWNERSHIP OF MANAGEMENT AND
CERTAIN BENEFICIAL OWNERS
The following table sets forth, as of April 3, 2000, information regarding
the beneficial ownership of Common Stock (i) by each Director (each of whom is a
nominee for election at the Annual Meeting), (ii) by each Executive Officer
listed in the Summary Compensation table below, (iii) by all Directors and
current Executive Officers as a group (five (5) persons), and (iv) by each
person or group known by the Company to own beneficially in excess of five
percent (5%) of the Common Stock:
Name and Address Amount and Nature of
of Beneficial Owner(4) Beneficial Ownership Percent of Class
---------------------- -------------------- ----------------
Gary H. Schlatter 7,458,700 shares(1) 81.4%(1)
2901 South Tejon Street
Englewood, Colorado 80110
Allen R. Goldstone 171,250 shares(2) 1.9%
5353 Manhattan Circle
Suite 201
Boulder, Colorado 80303
Michael I. Friess 27,250 shares(3) *
5353 Manhattan Circle
Suite 201
Boulder, Colorado 80303
All directors and executive 7,657,200 shares(1, 2, 3) 83.5%
officers as a group (three persons)
* Less than one percent
- ------------------
6
<PAGE>
(1) Includes 200,000 shares held by The Schlatter Family Partnership, of which
Gary H. Schlatter and his spouse are the general partners. Mr. Schlatter's
spouse may be deemed the beneficial owner of some or all of the shares.
Does not include 24,400 shares which Mr. Schlatter's spouse has the right
to acquire on April 3, 2000, or within sixty (60) days thereafter, pursuant
to outstanding options.
(2) Includes 1,250 shares which he has the right to acquire on April 3, 2000,
or within sixty (60) days thereafter, pursuant to outstanding options.
(3) Includes 11,250 shares which he has the right to acquire on April 3, 2000,
or within sixty (60) days thereafter, pursuant to outstanding options.
(4) Unless otherwise noted, the stockholders identified in this table have sole
voting and investment power. The sole person known to the Company to be the
beneficial owner of more than five percent (5%) of the class of outstanding
stock is Gary H. Schlatter, whose address is c/o OraLabs Holding Corp.,
2901 South Tejon Street, Englewood, Colorado 80110.
Change in Control.
The Company does not know of any arrangements, including a pledge by any
person of securities of the Company, the operation of which at a subsequent date
may result in a change in control of the Company.
EXECUTIVE COMPENSATION
The following table sets forth information regarding compensation for
services rendered, in all capacities, awarded or paid to or earned by the Chief
Executive Officer of the Company during the last three fiscal years. No other
executive officer of the Company received a total annual salary and bonus in
excess of $100,000 during the fiscal year ended December 31, 1999.
<TABLE>
<CAPTION>
Summary Compensation Table
Annual Compensation Long Term Compensation
------------------------------------ ----------------------------
Name and Shares Under-
Principal Position Year Salary ($) Bonuses ($) Other ($) Other lying Options (#)(2)
- ------------------ ---- ---------- ----------- --------- ----- --------------------
<S> <C> <C> <C> <C> <C> <C>
Gary H. Schlatter, 1999 239,038 0 26,887(3) 0 61,000
Chief Executive 1998 163,040 0 19,482(3) 0 61,000
Officer 1997 53,333(1) 0 714,607(1) 0 61,000
</TABLE>
(1) On May 1, 1997, the Company's subsidiary, OraLabs, Inc., was acquired by
the Company's predecessor, SSI Capital Corp., in a transaction commonly
referred to as a reverse triangular merger. SSI Capital Corp. subsequently
7
<PAGE>
merged with OraLabs Holding Corp., with OraLabs Holding Corp. becoming the
surviving company. Prior to May 1, 1997, OraLabs, Inc. was a privately
held, subchapter S corporation, owned 100% by Mr. Schlatter. As Mr.
Schlatter recognized for tax purposes all income of the subchapter S
corporation whether distributed to him or not, it was the practice of the
privately held entity to distribute substantially all of such income to Mr.
Schlatter each year. Accordingly, the entry in the column entitled "Other"
for 1997 consists of the distributions received by Mr. Schlatter from
OraLabs, Inc. during the first four (4) months of the calendar year, and
the salary paid to Mr. Schlatter in 1997 represents payments made by the
Company for the period from May 1, 1997 through fiscal year end.
(2) Includes 61,000 shares underlying 61,000 options granted in the fiscal year
ended December 31, 1997 to Mr. Schlatter's spouse under the Company's 1997
Stock Plan. Beneficial ownership of such securities is disclaimed by Mr.
Schlatter.
(3) Includes expenses for automobiles and related insurance and other
automobile expenses.
Standard Compensation Arrangements
There were no standard arrangements in fiscal year 1999 pursuant to which
directors of the Company were compensated for any services provided as a
director. The Company may institute such arrangements, which may include, but
not be limited to, standard fees for attendance at meetings of directors and/or
committees. There were no other arrangements pursuant to which any director of
the Company was compensated during the past fiscal year for any service provided
as a director. However, the Company has a Non-Employee Director Stock Option
Plan under which directors who are not employees are granted (at the time of
initial election or appointment to the Board) 20,000 options to purchase common
stock and are thereafter granted 5,000 options annually so long as they continue
to serve as non-employee directors. All of the options are exercisable at the
market price of the common stock at the time of grant and vest proportionately
over a four year period.
Other Compensation Arrangements
In January 2000, Mr. Friess was paid a one-time fee of $30,000 in
recognition of the additional services provided by him in connection with the
Pecos Pharmaceutical transaction described in "Certain Relationships and Related
Transactions".
As a result of the additional work involved in assisting the Company when
criminal charges were filed against its President (which charges were
subsequently dismissed, as discussed at "Involvement in Certain Legal
Proceedings" above), and because of the extra work anticipated to be required by
the disinterested directors to fulfill their responsibilities of determining
8
<PAGE>
whether to give prior approval to certain significant transactions by the
Company, it was agreed in January 2000 that the disinterested directors would
receive additional compensation for an indefinite period. The transactions for
which approval by the disinterested board members was required included those
that are other than in the ordinary course of business and which have a value of
over $100,000 or which involve a commitment by the Company of incentives to a
single customer of more than that amount; obtaining new governmental licenses
other than renewals or extensions; incurring Company debt; certain employment
decisions involving management and key personnel; execution of new leases or
lease renewals of real property; acquisitions of capital equipment in excess of
$50,000; and launching of new product lines not already in development. Under
those arrangements which were terminated on April 13, 2000, Mr. Friess and Mr.
Goldstone were paid the sum of $4,000 each per month for their services as
directors. Effective April 1, 2000, those amounts were reduced to $2,000 per
month.
Agreements with Executive Officers
The only employment contract between the Company and any executive officer
of the Company who received total salary and bonus during fiscal year 1999 in
excess of $100,000 is an Amended and Restated Employment Agreement with Gary H.
Schlatter. Except for that Agreement as described below, the Company has not
entered into any compensatory arrangement pursuant to which any executive
officer of the Company will receive payment from the Company as a result of the
executive officer's resignation, retirement or termination of employment or as a
result of a change in control of the Company.
Effective April 25, 1997, the Company's subsidiary, OraLabs, Inc., entered
into an Amended and Restated Employment Agreement with Gary Schlatter. The
Agreement is for a term of three (3) years commencing May 1, 1997 and
terminating April 30, 2000, unless terminated earlier pursuant to the provisions
of the Agreement. Under the Agreement, Mr. Schlatter agrees to devote such time
and attention to the business of OraLabs, Inc. as may be required to fulfill his
duties, which is expected to require a substantial amount of his working time.
Under the Agreement, Mr. Schlatter was paid a base salary of $80,000 per
year for the first twelve (12) months, $220,000 per year for the next twelve
(12) months, and $242,000 for the final twelve (12) months. Bonus compensation
is payable to Mr. Schlatter only as may be determined by the Board of Directors
in its discretion. Under the Agreement, Mr. Schlatter has agreed that during its
term and for a period of one (1) year thereafter, he will not participate in any
business competitive to that of the business of OraLabs, Inc., except with
respect to limited passive investments, and that he will never disclose or
utilize any trade secrets or proprietary information of OraLabs, Inc. except
within the scope of his employment.
Under specified circumstances involving a change in control, Mr. Schlatter
may terminate the Agreement and receive a lump sum payment equal to all of the
compensation to which he otherwise would have been entitled had the Agreement
remained in effect for its entire term.
9
<PAGE>
SELECTION OF INDEPENDENT AUDITORS
The Board of Directors has selected Ehrhardt Keefe Steiner & Hottman P.C.
as the independent auditors to audit the books and accounts of the Company for
the current fiscal year. Ehrhardt Keefe Steiner & Hottman P.C. has served as
such independent auditors since December 29, 1998. One or more representatives
of Ehrhardt Keefe Steiner & Hottman P.C. will be present at the Annual Meeting,
will have an opportunity to make a statement if they desire to do so and will
respond to appropriate questions.
From May 1, 1997, to December 28, 1998, Schumacher & Associates, Inc.
served as the Company's independent auditors. The firm was dismissed by the
Board of Directors of the Company and there were no disagreements with the
former accounting firm. The financial statements for the past two fiscal years
do not contain an adverse opinion or disclaimer of opinion and were not modified
as to uncertainty, audit scope or accounting principles.
The Board of Directors recommends that the stockholders vote FOR approval
of the selection of Ehrhardt Keefe Steiner & Hottman P.C. as the Company's
independent auditors.
STOCKHOLDERS PROPOSALS FOR NEXT ANNUAL MEETING
Stockholders of the Company wishing to include proposals in the proxy
material relating to the 2001 Annual Meeting of Stockholders of the Company must
submit the same in writing so as to be received at the principal executive
office of the Company (to the attention of the Secretary) on or before December
28, 2000 for such proposal to be considered for inclusion in the proxy statement
for such meeting. Such proposals must also meet the other requirements of the
rules of the Securities and Exchange Commission relating to stockholder
proposals.
Stockholders who wish to submit any items of business to be addressed at an
annual meeting of stockholders (rather than include the item in the proxy
material) must make the submission in a timely manner as provided in the
Company's Amended and Restated Bylaws. The Bylaws provide that only timely
submissions of business items will be considered as proper business at the
meeting. To be timely, a stockholder's written submission must be delivered to
or mailed and received at, the principal business offices of the Company at
least sixty (60) days in advance of the date that the Company's proxy statement
was released to stockholders in connection with the previous year's annual
meeting of stockholders. As this proxy statement for the 2000 annual meeting is
being released on April 27, 2000, the deadline for submissions of business items
for the 2000 annual meeting will be February 26, 2001. The Bylaws also specify
what must be included in the written notice of submission in order for the
submission to be considered timely and to be considered proper business to be
conducted at the annual meeting.
10
<PAGE>
OTHER MATTERS
The Board of Directors does not know of any other business to be presented
for consideration at the Annual Meeting. If other matters properly come before
the Annual Meeting, the persons named in the accompanying proxy intend to vote
thereon in accordance with their best judgment.
The Company's Annual Report on Form 10-KSB for the fiscal year ended
December 31, 1999 accompanies this Proxy Statement and constitutes the Company's
Annual Report to stockholders. Copies of any exhibits thereto will be furnished
to any stockholder of the Company upon the payment of a reasonable duplicating
charge. Written requests for any exhibit should be directed to OraLabs Holding
Corp., 2901 South Tejon Street, Englewood, Colorado 80110, Attention: Investor
Relations.
SOLICITATION AND EXPENSES
The Company will bear the cost of the Annual Meeting and the cost of
soliciting proxies, including the cost of mailing the proxy materials. In
addition to solicitation by mail, Directors, officers and regular employees of
the Company (who will not be specifically compensated for such services) may
solicit proxies by telephone or otherwise. Arrangements will be made with
brokerage houses and other custodians, nominees and fiduciaries to forward
proxies and proxy material to their principals and the Company will reimburse
them for their expenses.
By Order of the Board of Directors,
/s/ Gary H. Schlatter
---------------------
Gary H. Schlatter,
Chairman of the Board
April 24, 2000.
11
<PAGE>
ORALABS HOLDING CORP.
PROXY SOLICITED ON BEHALF OF COMPANY'S
BOARD OF DIRECTORS
ANNUAL MEETING OF STOCKHOLDERS
May 25, 2000
The undersigned hereby appoints as proxies Gary H. Schlatter, Michael I.
Friess and Allen R. Goldstone and each of them (with power of substitution) to
vote for the undersigned all shares of common stock of the undersigned at the
annual meeting of stockholders and any adjournment thereof with all the power
the undersigned would have if personally present. The shares represented will be
voted as instructed. Unless indicated to the contrary, this proxy shall be
deemed to grant authority to vote "FOR" all proposals.
PLEASE INDICATE YOUR VOTE BY AN "X" IN THE APPROPRIATE BOX BELOW
1. ELECTION OF DIRECTORS [ ] [ ] [ ]
(Instructions: To withhold FOR ALL FOR ALL WITHHOLD
authority to vote for an EXCEPT AUTHORITY
individual nominee, strike a FOR ALL
line through the nominee's
name in the list below and
mark center box to right.)
Nominees: Gary H. Schlatter, Allen R. Goldstone and Michael I. Friess
2. Proposal to ratify Ehrhardt Keefe [ ] [ ] [ ]
Steiner & Hottman P.C. as the FOR AGAINST ABSTAIN
independent auditors for the
fiscal year ended December 31,
2000
In their discretion, the proxy holders are authorized to vote upon such
other matters as may properly come before the Annual Meeting of Stockholders and
at any adjournment(s) thereof. The Board of Directors at present knows of no
other business to be presented by or on behalf of the Company or the Board of
Directors at the Annual Meeting of Stockholders.
- --------------------------------- ----------------------------------------
Signature Signature if Held Jointly
- --------------------------------- ----------------------------------------
Name (Please Print) Name (Please Print)
- --------------------------------- ----------------------------------------
Date: Date:
